Faculty

Back to Index
Peggy Farnham, PhD
Chair and Professor of Biochemistry & Molecular Medicine
W.M. Keck Chair in Biochemistry
Biochemistry and Molecular Biology
NRT 511 B 1450 Biggy Street Health Sciences Campus Los Angeles
+1 323 442 8015

Overview

Dr. Farnham is the William M. Keck Professor of Biochemistry and the Chair of the Department of Biochemistry and Molecular Biology at the Keck School of Medicine at the University of Southern California in Los Angeles, California. Dr. Farnham received her bachelor’s degree from Rice University, her Ph.D. from Yale University, and performed her post-doctoral training at Stanford University. Dr. Farnham previously held Professorships at the McArdle Laboratory for Cancer Research at the University of Wisconsin-Madison and at the University of California-Davis where she was the Associate Director of the UC Davis Genome Center. Dr. Farnham is an international leader in the study of chromatin regulation and its control of transcription factor binding and function. She is a member of an international consortia of genomic scientists working on the ENCODE (Encyclopedia of DNA elements) Project and a member of an NIH Roadmap Reference Epigenome Mapping Center. Based on her contributions to biomedical research, she was elected as a fellow of AAAS in 2010 and in 2012 she received the ASBMB Herbert A Sober Award, which recognizes outstanding biochemical and molecular biological research with particular emphasis on the development of methods and techniques to aid in research.

Research Interests: transcriptional genomics, genomic technologies
Diseases Models: cancer cells and tissues, cultured neuroepithelial cells
Consortia: ENCODE, Roadmap Epigenome Mapping Centers, PsychENCODE

Awards

ASBMB Herbert A. Sober Award

AAAS Fellow

Publications

Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells. Nucleic Acids Res. 2016 May 19; 44(9):4123-33. View in: PubMed

4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus. Sci Rep. 2016 Mar 03; 6:22462. View in: PubMed

Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics Chromatin. 2016; 9:50. View in: PubMed

The PsychENCODE project. Nat Neurosci. 2015 Dec; 18(12):1707-12. View in: PubMed

Inferring regulatory element landscapes and transcription factor networks from cancer methylomes. Genome Biol. 2015 May 21; 16:105. View in: PubMed

The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Res. 2015 Apr; 25(4):467-77. View in: PubMed

Integrative analysis of 111 reference human epigenomes. Nature. 2015 Feb 19; 518(7539):317-30. View in: PubMed

Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015 Feb 18; 6:6363. View in: PubMed

Epigenetic and transcriptional determinants of the human breast. Nat Commun. 2015 Feb 18; 6:6351. View in: PubMed

Altering cancer transcriptomes using epigenomic inhibitors. Epigenetics Chromatin. 2015; 8:9. View in: PubMed

Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes. Crit Rev Biochem Mol Biol. 2015; 50(6):550-73. View in: PubMed

Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenetics Chromatin. 2015; 8:57. View in: PubMed

Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014 Nov 25; 5:5442. View in: PubMed

Functional annotation of colon cancer risk SNPs. Nat Commun. 2014 Sep 30; 5:5114. View in: PubMed

Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes. Genome Biol. 2014 Sep 20; 15(9):469. View in: PubMed

Reply to Brunet and Doolittle: Both selected effect and causal role elements can influence human biology and disease. Proc Natl Acad Sci U S A. 2014 Aug 19; 111(33):E3366. View in: PubMed

Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. BMC Genomics. 2014 Jun 24; 15:520. View in: PubMed

Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A. 2014 Apr 29; 111(17):6131-8. View in: PubMed

Can genome engineering be used to target cancer-associated enhancers? Epigenomics. Can genome engineering be used to target cancer-associated enhancers? Epigenomics. 2014; 6(5):493-501. View in: PubMed

Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation. Nucleic Acids Res. 2014; 42(16):10856-68. View in: PubMed

Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet. 2014 Jan; 10(1):e1004102. View in: PubMed

Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem. 2013 Nov 29; 288(48):34287-94. View in: PubMed

Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros. Nat Immunol. 2013 Oct; 14(10):1073-83. View in: PubMed

Recombinant antibodies to histone post-translational modifications. Nat Methods. 2013 Oct; 10(10):992-5. View in: PubMed

Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res. 2013 Sep; 23(9):1522-40. View in: PubMed

DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape. Nat Genet. 2013 Jul; 45(7):836-41. View in: PubMed

ZBTB33 binds unmethylated regions of the genome associated with actively expressed genes. Epigenetics Chromatin. 2013 May 21; 6(1):13. View in: PubMed

LOcating non-unique matched tags (LONUT) to improve the detection of the enriched regions for ChIP-seq data. PLoS One. 2013; 8(6):e67788. View in: PubMed

Spark: a navigational paradigm for genomic data exploration. Genome Res. 2012 Nov; 22(11):2262-9. View in: PubMed

Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. Genome Biol. 2012 Sep 26; 13(9):R52. View in: PubMed

Uncovering transcription factor modules using one- and three-dimensional analyses. J Biol Chem. 2012 Sep 07; 287(37):30914-21. View in: PubMed

Thematic minireview series on results from the ENCODE Project: Integrative global analyses of regulatory regions in the human genome. J Biol Chem. 2012 Sep 07; 287(37):30885-7. View in: PubMed

An integrated encyclopedia of DNA elements in the human genome. Nature. 2012 Sep 06; 489(7414):57-74. View in: PubMed

Integration of Hi-C and ChIP-seq data reveals distinct types of chromatin linkages. Nucleic Acids Res. 2012 Sep; 40(16):7690-704. View in: PubMed

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 2012 Sep; 22(9):1813-31. View in: PubMed

Human ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFß tumor suppressor signaling pathways. Mol Cancer Res. 2012 Jul; 10(7):979-91. View in: PubMed

Using ChIPMotifs for de novo motif discovery of OCT4 and ZNF263 based on ChIP-based high-throughput experiments. Methods Mol Biol. 2012; 802:323-34. View in: PubMed

The transcription factor encyclopedia. Genome Biol. 2012; 13(3):R24. View in: PubMed

Autophagy driven by a master regulator of hematopoiesis. Mol Cell Biol. 2012 Jan; 32(1):226-39. View in: PubMed

The Human Epigenome Browser at Washington University. Nat Methods. 2011 Nov 29; 8(12):989-90. View in: PubMed

Genetic framework for GATA factor function in vascular biology. Proc Natl Acad Sci U S A. 2011 Aug 16; 108(33):13641-6. View in: PubMed

KAP1 protein: an enigmatic master regulator of the genome. J Biol Chem. 2011 Jul 29; 286(30):26267-76. View in: PubMed

L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol Cell. 2011 May 20; 42(4):438-50. View in: PubMed

Functional analysis of KAP1 genomic recruitment. Mol Cell Biol. 2011 May; 31(9):1833-47. View in: PubMed

Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome. J Biol Chem. 2011 Apr 08; 286(14):11985-96. View in: PubMed

A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011 Apr; 9(4):e1001046. View in: PubMed

Characterization of the contradictory chromatin signatures at the 3' exons of zinc finger genes. PLoS One. 2011 Feb 15; 6(2):e17121. View in: PubMed

Using ChIP-seq technology to generate high-resolution profiles of histone modifications. Methods Mol Biol. 2011; 791:265-86. View in: PubMed

Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation. PLoS One. 2011; 6(11):e27740. View in: PubMed

Transcription factor effector domains. Subcell Biochem. 2011; 52:261-77. View in: PubMed

ZNF274 recruits the histone methyltransferase SETDB1 to the 3' ends of ZNF genes. PLoS One. 2010 Dec 08; 5(12):e15082. View in: PubMed

Genome-wide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes. BMC Genomics. 2010 Dec 02; 11:689. View in: PubMed

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. Oncogene. 2010 Oct 07; 29(40):5500-10. View in: PubMed

The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol. 2010 Oct; 28(10):1045-8. View in: PubMed

Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol. 2010 Oct; 28(10):1097-105. View in: PubMed

5-azacytidine treatment reorganizes genomic histone modification patterns. Epigenetics. 2010 Apr; 5(3):229-40. View in: PubMed

Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem. 2010 Jan 08; 285(2):1393-403. View in: PubMed

Using ChIP-seq technology to identify targets of zinc finger transcription factors. Methods Mol Biol. 2010; 649:437-55. View in: PubMed

Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res. 2010 Jan; 38(3):e13. View in: PubMed

W-ChIPMotifs: a web application tool for de novo motif discovery from ChIP-based high-throughput data. Bioinformatics. 2009 Dec 01; 25(23):3191-3. View in: PubMed

Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell. 2009 Nov 25; 36(4):667-81. View in: PubMed

Insights from genomic profiling of transcription factors. Nat Rev Genet. 2009 Sep; 10(9):605-16. View in: PubMed

N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res. 2008 Dec 01; 68(23):9654-62. View in: PubMed

E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites. Genome Res. 2008 Nov; 18(11):1763-77. View in: PubMed

Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res. 2008 Apr 15; 68(8):2641-51. View in: PubMed

Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res. 2008 Apr; 18(4):521-32. View in: PubMed

Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res. 2008 Mar; 18(3):393-403. View in: PubMed

Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A. 2007 Dec 04; 104(49):19416-21. View in: PubMed

Genome-scale ChIP-chip analysis using 10,000 human cells. Biotechniques. 2007 Dec; 43(6):791-7. View in: PubMed

A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res. 2007 Nov; 17(11):1550-61. View in: PubMed

Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007 Jun 29; 129(7):1311-23. View in: PubMed

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007 Jun 14; 447(7146):799-816. View in: PubMed

Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet. 2007 Jun; 3(6):e89. View in: PubMed

Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches. Genome Res. 2007 Jun; 17(6):807-17. View in: PubMed

Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays. J Biol Chem. 2007 Mar 30; 282(13):9703-12. View in: PubMed

Locating mammalian transcription factor binding sites: a survey of computational and experimental techniques. Genome Res. 2006 Dec; 16(12):1455-64. View in: PubMed

A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1. Genome Res. 2006 Dec; 16(12):1585-95. View in: PubMed

Comparison of sample preparation methods for ChIP-chip assays. Biotechniques. 2006 Nov; 41(5):577-80. View in: PubMed

Suz12 binds to silenced regions of the genome in a cell-type-specific manner. Genome Res. 2006 Jul; 16(7):890-900. View in: PubMed

Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 2006 May; 16(5):595-605. View in: PubMed

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci U S A. 2005 Feb 08; 102(6):1859-64. View in: PubMed

CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res. 2005; 33(9):2952-61. View in: PubMed

The use of transient chromatin immunoprecipitation assays to test models for E2F1-specific transcriptional activation. J Biol Chem. 2004 Oct 29; 279(44):46343-9. View in: PubMed

Genomic approaches that aid in the identification of transcription factor target genes. Exp Biol Med (Maywood). 2004 Sep; 229(8):705-21. View in: PubMed

Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 2004 Jul 01; 18(13):1592-605. View in: PubMed

T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity. 2004 Apr; 20(4):477-94. View in: PubMed

High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 2004; 376:315-34. View in: PubMed

E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J Biol Chem. 2003 Oct 24; 278(43):42466-76. View in: PubMed

Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr Biol. 2003 May 13; 13(10):882-6. View in: PubMed

Identification and characterization of CRG-L2, a new marker for liver tumor development. Oncogene. 2003 Mar 20; 22(11):1730-6. View in: PubMed

Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene. 2003 Mar 13; 22(10):1445-60. View in: PubMed

Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther. 2003 Jan; 2(1):113-21. View in: PubMed

Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins. Methods Enzymol. 2003; 371:577-96. View in: PubMed

Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem. 2002 Oct 18; 277(42):40156-62. View in: PubMed

The identification of E2F1-specific target genes. Proc Natl Acad Sci U S A. 2002 Mar 19; 99(6):3890-5. View in: PubMed

Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 2002 Jan 15; 16(2):235-44. View in: PubMed

Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods. 2002 Jan; 26(1):37-47. View in: PubMed

In vivo assays to examine transcription factor localization and target gene specificity. Methods. 2002 Jan; 26(1):1-2. View in: PubMed

Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods. 2002 Jan; 26(1):48-56. View in: PubMed

c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem. 2001 Dec 21; 276(51):48562-71. View in: PubMed

Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol. 2001 Oct; 21(20):6820-32. View in: PubMed

Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol. 2001 Sep; 21(17):6006-16. View in: PubMed

The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements. J Biol Chem. 2001 Jun 08; 276(23):20482-90. View in: PubMed

Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. J Mol Biol. 2001 May 25; 309(1):99-120. View in: PubMed

Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene. 2001 May 10; 20(21):2704-12. View in: PubMed

Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. J Biol Chem. 2000 Oct 27; 275(43):33798-805. View in: PubMed

Direct recruitment of N-myc to target gene promoters. Mol Carcinog. 2000 Oct; 29(2):76-86. View in: PubMed

Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol. 2000 Aug; 20(16):5797-807. View in: PubMed

Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation. Oncogene. 2000 Apr 27; 19(18):2257-68. View in: PubMed

CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines. Mol Carcinog. 2000 Feb; 27(2):84-96. View in: PubMed

Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol Cell Biol. 1999 Dec; 19(12):8393-9. View in: PubMed

Context-dependent transcriptional regulation. J Biol Chem. 1999 Oct 15; 274(42):29583-6. View in: PubMed

Identification of target genes of oncogenic transcription factors. Proc Soc Exp Biol Med. 1999 Oct; 222(1):9-28. View in: PubMed

No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Mol Carcinog. 1999 Aug; 25(4):295-303. View in: PubMed

Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J Biol Chem. 1999 May 28; 274(22):15883-91. View in: PubMed

Characterization of the 3' untranslated region of mouse E2F1 mRNA. Gene. 1998 Nov 26; 223(1-2):355-60. View in: PubMed

c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13887-92. View in: PubMed

E2F-mediated growth regulation requires transcription factor cooperation. J Biol Chem. 1997 Jul 18; 272(29):18367-74. View in: PubMed

Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol Cell Biol. 1997 May; 17(5):2529-37. View in: PubMed

Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol Cell Biol. 1997 Apr; 17(4):1966-76. View in: PubMed

Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol. 1996; 208:1-30. View in: PubMed

Conclusions and future directions. Curr Top Microbiol Immunol. 1996; 208:129-37. View in: PubMed

Transcriptional regulation of the dihydrofolate reductase gene. Bioessays. 1996 Jan; 18(1):55-62. View in: PubMed

Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of CB57BL/6J and C3H/HeJ mice. Mol Carcinog. 1995 Sep; 14(1):46-52. View in: PubMed

The bidirectionally transcribed dihydrofolate reductase and rep-3a promoters are growth regulated by distinct mechanisms. Cell Growth Differ. 1995 May; 6(5):541-8. View in: PubMed

v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1. Cell Growth Differ. 1995 May; 6(5):549-56. View in: PubMed

An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol. 1995 May; 15(5):2527-35. View in: PubMed

Identification of cis-acting elements that can obviate a requirement for the C-terminal domain of RNA polymerase II. J Biol Chem. 1995 Mar 24; 270(12):6798-807. View in: PubMed

Inappropriate transcription from the 5' end of the murine dihydrofolate reductase gene masks transcriptional regulation. Nucleic Acids Res. 1994 Aug 11; 22(15):3061-8. View in: PubMed

Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 1994 Jul 01; 8(13):1526-37. View in: PubMed

Cloning, chromosomal location, and characterization of mouse E2F1. Mol Cell Biol. 1994 Mar; 14(3):1861-9. View in: PubMed

Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J Biol Chem. 1994 Jan 21; 269(3):2252-7. View in: PubMed

Transcriptional regulation of the dihydrofolate reductase/rep-3 locus. Crit Rev Eukaryot Gene Expr. 1994; 4(1):19-53. View in: PubMed

The role of E2F in the mammalian cell cycle. Biochim Biophys Acta. 1993 Aug 23; 1155(2):125-31. View in: PubMed

An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes. J Biol Chem. 1993 Jul 25; 268(21):15674-80. View in: PubMed

Site-specific initiation of transcription by RNA polymerase II. Proc Soc Exp Biol Med. 1993 Jun; 203(2):127-39. View in: PubMed

A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol. 1993 Mar; 13(3):1610-8. View in: PubMed

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 1992 Jul 24; 70(2):351-64. View in: PubMed

krox 20 messenger RNA and protein expression in the adult central nervous system. Brain Res Mol Brain Res. 1992 Jun; 14(1-2):117-23. View in: PubMed

The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II. Mol Cell Biol. 1992 May; 12(5):2250-9. View in: PubMed

The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol Cell Biol. 1992 Mar; 12(3):1054-63. View in: PubMed

Heat sensitivity and Sp1 activation of complex formation at the Syrian hamster carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter in vitro. J Biol Chem. 1992 Jan 05; 267(1):385-91. View in: PubMed

Cell cycle analysis of Krox-20, c-fos, and JE expression in proliferating NIH3T3 fibroblasts. Cell Growth Differ. 1991 Sep; 2(9):465-73. View in: PubMed

Sp1 activation of RNA polymerase II transcription complexes involves a heat-labile DNA-binding component. Gene Expr. 1991 May; 1(2):137-48. View in: PubMed

Identification of the serum-responsive transcription initiation site of the zinc finger gene Krox-20. Mol Cell Biol. 1990 Jul; 10(7):3788-91. View in: PubMed

Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene. Cell Growth Differ. 1990 Apr; 1(4):179-89. View in: PubMed

Sequences downstream of the transcription initiation site modulate the activity of the murine dihydrofolate reductase promoter. Mol Cell Biol. 1990 Apr; 10(4):1390-8. View in: PubMed

Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site. Mol Cell Biol. 1990 Feb; 10(2):653-61. View in: PubMed

Identification of a new promoter upstream of the murine dihydrofolate reductase gene. Mol Cell Biol. 1989 Oct; 9(10):4568-70. View in: PubMed

In vitro transcription and delimitation of promoter elements of the murine dihydrofolate reductase gene. Mol Cell Biol. 1986 Jul; 6(7):2392-401. View in: PubMed

Murine dihydrofolate reductase transcripts through the cell cycle. Mol Cell Biol. 1986 Feb; 6(2):365-71. View in: PubMed

Transcriptional regulation of mouse dihydrofolate reductase in the cell cycle. J Biol Chem. 1985 Jun 25; 260(12):7675-80. View in: PubMed

Opposite-strand RNAs from the 5' flanking region of the mouse dihydrofolate reductase gene. Proc Natl Acad Sci U S A. 1985 Jun; 82(12):3978-82. View in: PubMed

Heterogeneity at the 5' termini of mouse dihydrofolate reductase mRNAs. Evidence for multiple promoter regions. J Biol Chem. 1985 Feb 25; 260(4):2307-14. View in: PubMed

Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line. Proc Natl Acad Sci U S A. 1985 Feb; 82(4):1126-30. View in: PubMed

Effects of NusA protein on transcription termination in the tryptophan operon of Escherichia coli. Cell. 1982 Jul; 29(3):945-51. View in: PubMed

Effects of DNA base analogs on transcription termination at the tryptophan operon attenuator of EScherichia coli. Proc Natl Acad Sci U S A. 1982 Feb; 79(4):998-1002. View in: PubMed

Synthetic sites for transcription termination and a functional comparison with tryptophan operon termination sites in vitro. Proc Natl Acad Sci U S A. 1981 Jul; 78(7):4180-4. View in: PubMed

Rho-independent termination: dyad symmetry in DNA causes RNA polymerase to pause during transcription in vitro. Nucleic Acids Res. 1981 Feb 11; 9(3):563-77. View in: PubMed

A model for transcription termination suggested by studies on the trp attenuator in vitro using base analogs. Cell. 1980 Jul; 20(3):739-48. View in: PubMed

Effects of gentamicin on trypsin, chymotrypsin, and collagenase. J Infect Dis. 1978 Aug; 138(2):257-9. View in: PubMed

A re-examination of the distributions of octopamine and phenylethanolamine in the aplysia nervous system. J Neurochem. 1978 May; 30(5):1173-6. View in: PubMed

Powered bySC CTSI